Literature DB >> 23470682

The usefulness of the anaerobic threshold in the assessment and prognostic evaluation of the patient with dyspnea.

Rosalinda Madonna1, Raffaele De Caterina, Roberto Bolli.   

Abstract

The anaerobic threshold (AT) is defined as the oxygen consumption level above which energy production becomes determined by anaerobic metabolism, which causes a sustained increase in lactate and metabolic acidosis. The AT, as measured by cardiopulmonary stress testing, is ubiquitously used to determine the prognosis and diagnosis of cardiovascular and respiratory diseases. This measurement can help clinicians in the functional evaluation of patients and as guidance for rehabilitation and therapy. This article reviews the pathophysiological aspects and methods of measurement of the AT during a cardiopulmonary stress test, and its clinical use in assessing cardiac and respiratory diseases.

Entities:  

Mesh:

Year:  2012        PMID: 23470682     DOI: 10.3909/ricm0608

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  3 in total

1.  Cardiopulmonary Exercise Testing in Patients with Post-COVID-19 Syndrome.

Authors:  Leandro Barbagelata; Walter Masson; Diego Iglesias; Ezequiel Lillo; Juan Francisco Migone; Maria Laura Orazi; Joaquin Maritano Furcada
Journal:  Med Clin (Engl Ed)       Date:  2022-07-05

2.  Relationship of end-tidal oxygen partial pressure to the determinants of anaerobic threshold in post-myocardial infarction patients.

Authors:  Asami Ogura; Kazuhiro P Izawa; Shinji Sato; Hideto Tawa; Fumie Kureha; Masaaki Wada; Masashi Kanai; Ikko Kubo; Peter H Brubaker; Ryohei Yoshikawa; Yuichi Matsuda
Journal:  Heart Vessels       Date:  2021-05-14       Impact factor: 2.037

3.  Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection: A Cross-Sectional Study Israel.

Authors:  Yair Blumberg; Michael Edelstein; Kamal Abu Jabal; Ron Golan; Neta Tuvia; Yuval Perets; Musa Saad; Tatyana Levinas; Dabbah Saleem; Zeev Israeli; Abu Raya Alaa; Gabby Elbaz Greener; Anat Amital; Majdi Halabi
Journal:  J Clin Med       Date:  2022-07-29       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.